Some individuals report subjective improvement within days of initiating protocols
Current access rules remain unchanged
It is given as a small subcutaneous injection, usually in the evening about one hour after your last meal
Deeper understanding of the biological activity of coumarin and its derivatives, along with methods to improve their bioavailability, may lay a stronger foundation for their future therapeutic applications
These findings prompted further investigation into the synthetic version of the peptide, now known as Epithalon, to better understand its mechanisms of action and potential applications in human health
Dosing is individualized, but a typical protocol titrates from a starting dose up to a target dose over 2 to 4 weeks, injected 5 days on and 2 days off, in defined cycles with scheduled breaks between them